Misdiagnoses in prostate biopsy patients lead to $880M in healthcare costs On average, roughly one in every 200 patients undergoing a prostate biopsy are misdiagnosed due to their biopsy specimens ...
Some high-grade prostate cancers, such as intraductal carcinoma of the prostate, are not clearly visible on PSMA PET. For patients with intraductal carcinoma of the prostate (IDC-P), prostate-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback